| Serial Number | 79326219 |
| Word Mark | APEXP |
| Filing Date | Monday, September 27, 2021 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, March 28, 2023 |
| Registration Number | 7008451 |
| Registration Date | Tuesday, March 28, 2023 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, January 10, 2023 |
| Goods and Services | Downloadable software for the research and development of pharmaceutical compositions, pharmaceutical products, diagnostic reagents, antibiotics, biomarkers, enzymes and synthetic proteins in the field of infectious diseases and diseases caused by bacteria; downloadable computer software platforms for the research and development of pharmaceutical compositions, pharmaceutical products, diagnostic reagents, antibiotics, biomarkers, enzymes and synthetic proteins in the field of infectious diseases and diseases caused by bacteria; downloadable computer software using artificial intelligence for the research and development of pharmaceutical compositions, pharmaceutical products, diagnostic reagents, antibiotics, biomarkers, enzymes and synthetic proteins in the field of infectious diseases and diseases caused by bacteria; downloadable computer software platforms using artificial intelligence for the research and development of pharmaceutical compositions, pharmaceutical products, diagnostic reagents, antibiotics, biomarkers, enzymes and synthetic proteins in the field of infectious diseases and diseases caused by bacteria |
| Goods and Services | Software as a service (SaaS) services featuring software for the research and development of pharmaceutical compositions, pharmaceutical products, diagnostic reagents, antibiotics, biomarkers, enzymes and synthetic proteins in the field of infectious diseases and diseases caused by bacteria; software as a service (SaaS) services featuring artificial intelligence software for the research and development of pharmaceutical compositions, pharmaceutical products, diagnostic reagents, antibiotics, biomarkers, enzymes and synthetic proteins in the field of infectious diseases and diseases caused by bacteria; platform as a service (PaaS) services featuring software platforms for the research and development of pharmaceutical compositions, pharmaceutical products, diagnostic reagents, antibiotics, biomarkers, enzymes and synthetic proteins in the field of infectious diseases and diseases caused by bacteria; platform as a service (PaaS) services featuring software platforms using artificial intelligence for the research and development of pharmaceutical compositions, pharmaceutical products, diagnostic reagents, antibiotics, biomarkers, enzymes and synthetic proteins in the field of infectious diseases and diseases caused by bacteria; biomedical research services; scientific research for medical purposes in the field of infectious diseases and diseases caused by bacteria; research and development of pharmaceutical compositions, pharmaceutical products, diagnostic reagents, antibiotics, biomarkers, enzymes and synthetic proteins in the field of infectious diseases and diseases caused by bacteria; conducting clinical trials for others of pharmaceutical compositions, pharmaceutical products, diagnostic reagents, antibiotics, biomarkers, enzymes and synthetic proteins in the field of infectious diseases and diseases caused by bacteria |
| International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
| US Class Codes | 021, 023, 026, 036, 038 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, November 19, 2021 |
| Primary Code | 009 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, November 19, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | TELUM THERAPEUTICS S.L. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | ES |
| Party Name | TELUM THERAPEUTICS S.L. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | ES |
| Party Name | TELUM THERAPEUTICS S.L. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | ES |
| Event Date | Event Description |
| Monday, August 7, 2023 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Tuesday, July 18, 2023 | FINAL DISPOSITION NOTICE SENT TO IB |
| Tuesday, July 18, 2023 | FINAL DISPOSITION PROCESSED |
| Wednesday, June 28, 2023 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, March 28, 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, March 28, 2023 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, January 24, 2023 | NOTIFICATION PROCESSED BY IB |
| Tuesday, January 10, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, January 10, 2023 | PUBLISHED FOR OPPOSITION |
| Wednesday, January 4, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, January 4, 2023 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, December 21, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Friday, December 2, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, November 17, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, November 16, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, November 16, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, October 19, 2022 | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED |
| Thursday, October 6, 2022 | ATTORNEY REVIEW COMPLETED |
| Thursday, October 6, 2022 | LIMITATION FROM THE IB - REQUEST EXAM REVIEW |
| Tuesday, August 23, 2022 | REFUSAL PROCESSED BY IB |
| Friday, July 29, 2022 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Friday, July 29, 2022 | REFUSAL PROCESSED BY MPU |
| Sunday, July 3, 2022 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Saturday, July 2, 2022 | NON-FINAL ACTION WRITTEN |
| Tuesday, June 28, 2022 | ASSIGNED TO EXAMINER |
| Monday, June 20, 2022 | LIMITATION OF GOODS RECEIVED FROM IB |
| Sunday, May 29, 2022 | LIMITATION OF GOODS RECEIVED FROM IB |
| Tuesday, November 23, 2021 | APPLICATION FILING RECEIPT MAILED |
| Friday, November 19, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, November 18, 2021 | SN ASSIGNED FOR SECT 66A APPL FROM IB |